The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II neoadjuvant study (GeparNuevo) to investigate the addition of durvalumab to a taxane-anthracycline containing chemotherapy in triple negative breast cancer (TNBC).
 
Sibylle Loibl
Honoraria - Pfizer; Roche
Consulting or Advisory Role - Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Teva (Inst); Vifor Pharma (Inst)
 
Michael Untch
No Relationships to Disclose
 
Nicole Burchardi
No Relationships to Disclose
 
Jens Bodo Huober
Honoraria - Novartis; Roche
Consulting or Advisory Role - Novartis; Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Jens U. Blohmer
No Relationships to Disclose
 
Eva-Maria Grischke
No Relationships to Disclose
 
Jenny Furlanetto
No Relationships to Disclose
 
Hans Tesch
Honoraria - Roche
Consulting or Advisory Role - Roche
 
Claus Hanusch
Consulting or Advisory Role - Amgen; Celgene; Novartis; Roche
Speakers' Bureau - Amgen; Celgene; Novartis; Pfizer; Roche
 
Mahdi Rezai
No Relationships to Disclose
 
Christian Jackisch
No Relationships to Disclose
 
Wolfgang D Schmitt
Honoraria - AstraZeneca
 
Gunter Von Minckwitz
Stock and Other Ownership Interests - CARA GmbH
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Myriad Genetics (Inst); Pfizer (Inst); Roche (Inst); Vifor Pharma (Inst)
 
Jörg Thomalla
No Relationships to Disclose
 
Sherko Kummel
Honoraria - Amgen; Celgene; Daiichi Sankyo; Novartis; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Beate Rautenberg
Consulting or Advisory Role - Lilly; Roche
Research Funding - AstraZeneca (Inst); Lilly (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene
 
Peter A. Fasching
Honoraria - Amgen; Celgene; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst)
 
Kerstin Rhiem
Honoraria - AstraZeneca
 
Carsten Denkert
Stock and Other Ownership Interests - Sividon Diagnostics
Honoraria - Amgen; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - Amgen; MSD Oncology
Patents, Royalties, Other Intellectual Property - Predictive gene expression signature for therapy response; VMScope digital pathology software
 
Andreas Schneeweiss
Honoraria - Amgen; AstraZeneca; Celgene; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Pfizer (Inst); Roche Pharma AG (Inst)
Research Funding - Celgene (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Roche